Publicacions
-
Munoz-Almagro C, Gene-Giralt A, Pérez I, AUREA MIRA VALLET, Roca-Martínez J and Latorre C.
Diagnóstico de la tuberculosis en niños. Evaluación de la técnica reacción en cadena de la polimerasa.
ANALES DE PEDIATRIA . 47(4): 353-356.
-
Juncosa-Morros T, Munoz-Almagro C, Gene-Giralt A, Fortea Busquests J and Latorre Otín C.
Infecciones neonatales por Streptococcus agalactiae.
ANALES DE PEDIATRIA . 45(2): 153-156. Nº de cites: 1
-
Munoz-Almagro C, Juncosa-Morros T, Gene-Giralt A, Fortea J, Séculi JL and Latorre C.
[Microbiological study of the respiratory tract in children with cystic fibrosis].
ENFERMEDADES INFECCIOSAS Y MICROBIOLOGIA CLINICA . 14(3): 142-4. Nº de cites: 2
-
Gene-Giralt A, Fortea, J, Juncosa-Morros T, Munoz-Almagro C and Latorre, C.
[Evaluation of the E test method in the antimicrobial sensitivity of Neisseria meningitidis to penicillin].
ENFERMEDADES INFECCIOSAS Y MICROBIOLOGIA CLINICA . 13(5): 283-7. Nº de cites: 1
-
Fortea, J, Juncosa-Morros T, Gene-Giralt A, Munoz-Almagro C and Latorre, C.
Prevención de la infección neonatal por S. Agalactiae
JANO . (1137): 96-98.
-
Munoz-Almagro C, Trujillo, G, Latorre, C, Juncosa-Morros T and Huguet R.
[Osteoarticular infections in children].
ENFERMEDADES INFECCIOSAS Y MICROBIOLOGIA CLINICA . 10(5): 286-9. Nº de cites: 2
-
Shaw D, Torreblanca RA, Amin-Chowdhury Z, Bautista A, Bennett D, Broughton K, Casanova C, Choi EH, Claus H, Corcoran M, Cottrell S, Cunney R, Cuypers L, Dalby T, Davies H, de Gouveia L, Deghmane AE, Desmet S, Domenech M, Drew R, Plessis MD, Duarte C, Fuursted K, Golden A, Almeida SCG, Henares-Bonilla D, Henriques-Normark B, Hilty M, Hoffmann S, Humphreys H, Jacobsson S, Johnson C, Jolley KA, Kawabata A, Kozakova J, Kristinsson KG, Krizova P, Kuch A, Ladhani S, Lâm TT, Ayala MEL, Lindholm L, Litt D, Maiden MCJ, Martin I, Martiny D, Mattheus W, McCarthy ND, Meehan M, Meiring S, Mölling P, Morfeldt E, Morgan J, Mulhall R, Munoz-Almagro C, Murdoch D, Musilek M, Novakova L, Oftadeh S, Pérez-Argüello A, Pérez-Vázquez MD, Perrin M, Prevost B, Roberts M, Rokney A, Ron M, Sanabria OM, Scott KJ, Sempere J, Siira L, de Lemos APS, Sintchenko V, Skoczynska A, Slotved HC, Smith AJ, Taha MK, Toropainen M, Tzanakaki G, Vainio A, van der Linden MPG, van Sorge NM, Varon E, Moreno JV, Vohrnova S, von Gottberg A, Yuste J and Brueggemann AB.
The importance of microbiology reference laboratories and adequate funding for infectious disease surveillance.
LANCET DIGITAL HEALTH . : .
-
Garcia Quesada M, Peterson ME, Bennett JC, Hayford K, Zeger SL, Yang Y, Hetrich MK, Feikin DR, Cohen AL, von Gottberg A, van der Linden M, van Sorge NM, de Oliveira LH, de Miguel S, Yildirim I, Vestrheim DF, Verani JR, Varon E, Valentiner-Branth P, Tzanakaki G, Sinkovec Zorko N, Setchanova LP, Serhan F, Scott KJ, Scott JA, Savulescu C, Savrasova L, Reyburn R, Oishi K, Nuorti JP, Napoli D, Mwenda JM, Munoz-Almagro C, Morfeldt E, McMahon K, McGeer A, Mad'arová L, Mackenzie GA, Eugenia León M, Ladhani SN, Kristinsson KG, Kozakova J, Kleynhans J, Klein NP, Kellner JD, Jayasinghe S, Ho PL, Hilty M, Harker-Jones MA, Hammitt LL, Grgic-Vitek M, Gilkison C, Gierke R, French N, Diawara I, Desmet S, De Wals P, Dalby T, Dagan R, Corcoran M, Colzani E, Chanto Chacón G, Castilla J, Camilli R, Ang M, Ampofo K, Almeida SCG, Alarcon P, O'Brien KL and Deloria Knoll M.
Serotype distribution of remaining invasive pneumococcal disease after extensive use of ten-valent and 13-valent pneumococcal conjugate vaccines (the PSERENADE project): a global surveillance analysis.
LANCET INFECTIOUS DISEASES . : .
-
Savulescu C, Prats-Uribe A, Brolin K, Uusküla A, Bergin C, Fleming C, Zvirbulis V, Zavadska D, Szuldrzynski K, Gaio V, Popescu CP, Craiu M, Cisneros M, Latorre-Millán M, Lohur L, McGrath J, Ferguson L, Abolina I, Gravele D, Machado A, Florescu SA, Lazar M, Subirats P, Clusa Cuesta L, Sui J, Kenny C, Krievins D, Barzdina EA, Melo A, Kosa AG, Miron VD, Munoz-Almagro C, Milagro AM, Bacci S, Kramarz P and Nardone A.
Relative effectiveness of the second booster COVID-19 vaccines against laboratory confirmed SARS-CoV-2 infection in healthcare workers: VEBIS HCW VE cohort study (1 October 2022-2 May 2023).
Vaccine . 45: 126615-126615.